Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of Perioperative Assessed Biomarker I-FABP (Intestinal Fatty Acid-binding Protein) Level for Prediction of Acute Mesenteric Ischemia and Its Correlation With Acute Kidney Injury Followed by Extracorporeal Circulation

NCT06365827 is registered in ClinicalTrials.gov with University of Giessen as lead sponsor.

NCT NCT06365827
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06365827 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of Perioperative Assessed Biomarker I-FABP (Intestinal Fatty Acid-binding Protein) Level for Prediction of Acute Mesenteric Ischemia and Its Correlation With Acute Kidney Injury Followed by Extracorporeal Circulation
Lead sponsor
University of Giessen
Phase
Observational
Overall status
Completed
Start date
March 1, 2022
Completion date
December 31, 2024
Enrollment
500 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, acute mesenteric ischemia, cardiac surgery with cardiopulmonary bypass, non-occlusive mesenteric ischaemia